Seretide
Found 8 free book(s)2-1) 第三章 台灣目前常用吸入藥物
asthma-copd.tw商品名: Seretide Evohaler MDI 學名: Fluticasone propionate + Salmeterol 中文名: 使肺泰 定量吸入器 劑量: 50/25, 125/25, 250/25 μg / 劑 一般用法: 每12 小時，吸入1-2 劑 固定合併吸入型類固醇與 長效乙二型刺激劑( CS+L AB ) 商品名: S ertid A cuhal 學名: lu tic as on ep r+ S m
When to issue a steroid TREATMENT card or a steroid ...
www.dorsetccg.nhs.ukAloflute® and Seretide® ≥ 400 micrograms daily ≥ 200 micrograms daily Sirdupla® Only for use in adults over 18 years of age ≥ 400 micrograms daily Unlicensed – give with any dose Relvar Ellipta® Adults (>12 years). All patients should be given a steroid treatment card5 Unlicensed – give with any dose Trelegy Ellipta®
Lung function (breathing) tests
www.wsh.nhs.ukSalmeterol/Fluticasone - Seretide, Sirdupla, AirFluSal Formoterol/Budesonide - Symbicort, DuoResp Formoterol/Fluticasone - Flutiform Formoterol/Beclomethasone – Fostair 12 hours prior Theophylline, Phyllocontin, Uniphyllin, Bambuterol (tablets) 24 hours prior Lung Volumes
BPCO - Fiches IDE
www.fiches-ide.frUE 2.8 – Processus obstructifs fiches-ide.fr BPCO I. Définition et physiopathologie HAS : “La broncho-pneumopathie chronique obstructive est une maladie respiratoire chronique définie par …
COPD INHALER PRESCRIBING GUIDELINE
www.gloshospitals.nhs.ukDeveloped by the Formulary Subgroup of the Gloucestershire Respiratory Clinical Programme Group Review date: April 2022 Page 3 of 4 £0.00 £5.00 £10.00 £15.00 £20.00 £25.00
Situation n° 1 – Cas clinique - Infirmiers.com
www.infirmiers.com3 Question n°2 – 10.00 points Vous êtes infirmier(e) en service de pneumologie ce matin. (Lendemain de l’entrée en hospitalisation) A partir des problèmes et / ou risques médicaux et des diagnostics infirmiers que vous identifiez , citez les
INHALATORER – PULVER
www.janusinfo.seINHALATORER – PULVER SABA LABA ICS ICS+LABA LAMA LAMA+LABA LAMA+ LABA+ICS Onbrez (indakaterol) Atectura (indakaterol + mometason) Seebri (glykopyrron)
MANAGEMENT OF CHRONIC OBSTRUCTIVE PULMONARY …
www.moh.gov.my4 MANAGEMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE QUICK REFERENCE FOR HEALTH CARE PROVIDERS Figure 2: Algorithm for Managing Stable COPD in Resource-Limited Settings